======= ANXA5 ======= == Gene Information == * **Official Symbol**: ANXA5 * **Official Name**: annexin A5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=308|308]] * **UniProt**: [[https://www.uniprot.org/uniprot/P08758|P08758]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ANXA5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ANXA5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/131230|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene belongs to the annexin family of calcium-dependent phospholipid binding proteins some of which have been implicated in membrane-related events along exocytotic and endocytotic pathways. Annexin 5 is a phospholipase A2 and protein kinase C inhibitory protein with calcium channel activity and a potential role in cellular signal transduction, inflammation, growth and differentiation. Annexin 5 has also been described as placental anticoagulant protein I, vascular anticoagulant-alpha, endonexin II, lipocortin V, placental protein 4 and anchorin CII. The gene spans 29 kb containing 13 exons, and encodes a single transcript of approximately 1.6 kb and a protein product with a molecular weight of about 35 kDa. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: This protein is an anticoagulant protein that acts as an indirect inhibitor of the thromboplastin-specific complex, which is involved in the blood coagulation cascade. |Annexin| |negative regulation of prolactin secretion| |endothelial microparticle| |cellular response to lead ion| |phospholipase inhibitor activity| |cellular response to gonadotropin-releasing hormone| |response to gonadotropin-releasing hormone| |calcium transmembrane transporter activity, phosphorylative mechanism| |regulation of flagellated sperm motility| |regulation of cilium-dependent cell motility| |response to lead ion| |response to thyroid hormone| |peptide hormone binding| |negative regulation of peptide hormone secretion| |negative regulation of blood coagulation| |negative regulation of hemostasis| |negative regulation of coagulation| |calcium-dependent phospholipid binding| |negative regulation of sequestering of calcium ion| |receptor tyrosine kinase binding| |negative regulation of hormone secretion| |negative regulation of wound healing| |regulation of blood coagulation| |regulation of hemostasis| |regulation of coagulation| |negative regulation of response to wounding| |intracellular| |phospholipid binding| |regulation of sequestering of calcium ion| |platelet degranulation| |negative regulation of protein secretion| |regulation of wound healing| |negative regulation of peptide secretion| |response to calcium ion| |regulation of reproductive process| |regulation of response to wounding| |heparin binding| |negative regulation of protein transport| |negative regulation of establishment of protein localization| |cellular response to metal ion| |calcium ion transmembrane transport| |negative regulation of secretion by cell| |regulation of peptide hormone secretion| |cellular response to inorganic substance| |negative regulation of secretion| |calcium ion transport| |cellular response to peptide hormone stimulus| |regulation of hormone secretion| |blood coagulation| |coagulation| |divalent metal ion transport| |hemostasis| |divalent inorganic cation transport| |cellular response to peptide| |collagen-containing extracellular matrix| |negative regulation of response to external stimulus| |response to metal ion| |response to peptide hormone| |external side of plasma membrane| |focal adhesion| |regulation of protein secretion| |response to peptide| |wound healing| |negative regulation of transport| |regulation of peptide secretion| |regulation of body fluid levels| |response to inorganic substance| |regulation of hormone levels| |inorganic cation transmembrane transport| |response to wounding| |cellular response to organonitrogen compound| |cellular response to hormone stimulus| |cation transmembrane transport| |metal ion transport| |positive regulation of apoptotic process| |inorganic ion transmembrane transport| |positive regulation of programmed cell death| |cellular response to nitrogen compound| |positive regulation of cell death| |regulated exocytosis| |regulation of protein transport| |calcium ion binding| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |negative regulation of catalytic activity| |exocytosis| |regulation of secretion| |cation transport| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |response to hormone| |regulation of cell motility| |ion transmembrane transport| |regulation of locomotion| |negative regulation of cell death| |regulation of cellular component movement| |response to organonitrogen compound| |secretion by cell| |regulation of protein localization| |export from cell| |cellular response to oxygen-containing compound| |response to nitrogen compound| |regulation of response to external stimulus| |secretion| |negative regulation of molecular function| |negative regulation of multicellular organismal process| |cellular response to endogenous stimulus| |transmembrane transport| |negative regulation of cell communication| |negative regulation of signaling| |ion transport| |response to endogenous stimulus| |regulation of response to stress| |regulation of apoptotic process| |response to oxygen-containing compound| |regulation of programmed cell death| |negative regulation of response to stimulus| |regulation of cell death| |regulation of transport| |extracellular region| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp31|Rifampicin 1μM R00 exp31]]|1.75| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|1.75| |[[:results:exp533|TNF-alpha 44ng/ml R08 exp533]]|1.97| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|2.12| |[[:results:exp16|DABN 2μM R00 exp16]]|2.94| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8351 * **Expression level (log2 read counts)**: 5.21 {{:chemogenomics:nalm6 dist.png?nolink |}}